Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer

被引:382
作者
Verreck, G
Chun, I
Rosenblatt, J
Peeters, J
Van Dijck, A
Mensch, J
Noppe, M
Brewster, ME
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, Pharmaceut Sci, Drug Evaluat, B-2340 Beerse, Belgium
[2] Johnson & Johnson Ctr Biomat & Adv Technol, Somerville, NJ USA
关键词
electrostatic spinning; nanofibers; itraconazole; ketanserin; polyurethane;
D O I
10.1016/S0168-3659(03)00342-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Electrostatic spinning was applied to the preparation of drug-laden nonbiodegradable nanofiber for potential use in topical drug administration and wound healing. The specific aim of these studies was to assess whether these systems might be of interest as delivery systems for poorly water-soluble drugs. Itraconazole and ketanserin were selected as model compounds while a segmented polyurethane (PU) was selected as the nonbiodegradable polymer. For both itraconazole and ketanserin, an amorphous nanodispersion with PU was obtained when the drug/polymer solutions were electrospun from dimethylformide (DMF) and dimethylacetamide (DMAc), respectively. The collected nonwoven fabrics were shown to release the drugs at various rates and profiles based on the nanofiber morphology and drug content. Data were generated using a specially designed release apparatus based around a rotating cylinder. At low drug loading, itraconazole was released from the nanofibers as a linear function of the square root of time suggesting Fickian kinetics. No initial drug burst was observed. A biphasic release pattern was observed for ketanserin in which two sequential linear components were noted. These release phases may be temporally correlated with (1) drug diffusion through the polymer and (2) drug diffusion through formed aqueous pores. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:349 / 360
页数:12
相关论文
共 36 条
[1]  
[Anonymous], [No title captured], Patent No. 0154667
[2]  
APELQVIST J, 1990, INT ANGIOL, V9, P120
[3]   Processing and microstructural characterization of porous biocompatible protein polymer thin films [J].
Buchko, CJ ;
Chen, LC ;
Shen, Y ;
Martin, DC .
POLYMER, 1999, 40 (26) :7397-7407
[4]   Healing of full-thickness wounds in pigs: Effects of occlusive and non-occlusive dressings associated with a gel vehicle [J].
DeConinck, A ;
Draye, JP ;
VanStrubarq, A ;
Vanpee, E ;
Kaufman, L ;
Delaey, B ;
Verbeken, G ;
Roseeuw, D .
JOURNAL OF DERMATOLOGICAL SCIENCE, 1996, 13 (03) :202-211
[5]   Controlled deposition of electrospun poly(ethylene oxide) fibers [J].
Deitzel, JM ;
Kleinmeyer, JD ;
Hirvonen, JK ;
Tan, NCB .
POLYMER, 2001, 42 (19) :8163-8170
[6]   Electrospinning of polyurethane fibers [J].
Demir, MM ;
Yilgor, I ;
Yilgor, E ;
Erman, B .
POLYMER, 2002, 43 (11) :3303-3309
[7]  
DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
[8]  
Ghosh TK, 1997, TRANSDERMAL TOPICAL
[9]   A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis [J].
Gupta, AK ;
Shear, NH .
DRUG SAFETY, 2000, 22 (01) :33-52
[10]   Passive enhancement strategies in topical and transdermal drug delivery [J].
Hadgraft, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) :1-6